Nick,
In that their lender has the option of converting to shares at a discount to the current price, I believe that NWBO wants the share price dramatically higher before TLD is revealed if it is possible for them to do so. I believe that they're hoping that the update to Clinical Trials helps to spur that, but I'm not sure that they won't hold the actual statement until after their presentation at ASCO if they're not forced to do so by the Journal being published.
They were very careful not to put the presentation on their website as had they done so the lender could allege that it was their TLD statement. They led investors to the presentation, but officially steered clear of it coming from the company. I look forward to them doing it, but am willing to wait a few more weeks if that's what they insist on.
Gary
News 
Market Data 
Discover 
